ArticlePest management science2025
Immune priming of honey bees protects against a major microsporidian pathogen.
Article in Pest management science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microsporidia: evolution, infection mechanisms and host impact.Nature reviews. Microbiology · 2026Review
- Larval Metabolic and Physiological Mechanisms Underlying Resistance to Chinese Sacbrood Virus inInsects · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHoney bees face significant threats from pathogens like Nosema ceranae, a microsporidian parasite that contributes to global colony declines. Immune priming, exposure to pathogen antigens to stimulate protective responses, could mitigate infection risks. We tested whether priming honey bee larvae and adults with heat-killed N. ceranae spores reduces susceptibility to subsequent live infections in laboratory and field conditions.
resultsPriming consistently lowered infection levels and rates. The strongest effect occurred in laboratory-reared larvae, with a 97% reduction in mean spore counts relative to unprimed controls. Newly emerged adults primed and maintained in field colonies showed a 56% decrease, larvae primed by nurse bees in colonies had a 52% reduction, and newly emerged adults primed in laboratory cages showed a 34% reduction. Primed adults in field colonies also exhibited increased survival following live pathogen exposure as compared to positive controls. However, immune priming alone sometimes reduced bee lifespan. Priming altered expression of Toll pathway immune genes associated with Nosema resistance, particularly defensin-1.
conclusionImmune priming significantly protects honey bees from N. ceranae infection, reducing pathogen loads and enhancing survival across diverse conditions. Despite potential longevity trade-offs, these findings support immune priming as a viable strategy to improve honey bee health and to reduce microsporidian-induced colony losses. © 2025 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.